14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
JEF vs NMR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Jefferies Financial Group Inc. (JEF) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JEF carries a Unified Composite Score of 31.3/100 (SELL) at $42.63 (9.7x Forward P/E, 14.0% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin).
Technical & Structure Timing Caution: JEF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.6); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JEF vs NMR. Trailing 12-month operating profitability (JEF 14.0% vs NMR 25.1%) and valuation multiples (JEF 9.7x vs NMR 12.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $10.5B market capitalization and 14.0% operating margin.
OpEx & R&D Reinvestment68.6% of Rev ($5.84B)
90D Engineering Disclosures0 Published
NMR Moat ProfileScale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment52.3% of Rev ($7.77B)
90D Engineering Disclosures0 Published
Investor FAQ JEF vs NMR Key Questions & Quantitative Answers
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Jefferies Financial Group Inc. (JEF) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JEF carries a Unified Composite Score of 31.3/100 (SELL) at $42.63 (9.7x Forward P/E, 14.0% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin). Technical & Structure Timing Caution: JEF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.6); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NMR leads the Growth & Scale pillar: JEF posts +8.5% YoY revenue growth and +17.9% YoY earnings growth on $8.51B TTM revenue (82.6% gross margin, 14.0% operating margin), compared with NMR at +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin). On trailing 12-month operating scale, JEF generates $8.51B in USD-normalized revenue versus $14.9B for NMR. In operating R&D and SG&A reinvestment, JEF deploys 68.6% of Rev ($5.84B) (0 90-day corporate R&D disclosures) versus 52.3% of Rev ($7.77B) (0 disclosures) for NMR.
NMR screens cheaper on headline valuation multiples. JEF trades at 9.7x Forward P/E, 12.2x Trailing P/E, 1.09x PEG, and 2.5x EV/Revenue (49.3% FCF margin), whereas NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JEF (8.6% ROE) versus NMR (11.5% ROE) capital efficiency.
In options market volatility and institutional positioning, JEF carries 42.4% implied volatility (43rd %ile, Balanced (25th–60th %ile)), a 11.86x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.31β · 52% Vol realized risk). By comparison, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.